Author Guidelines

The International Journal of Chemistry and Pharmaceutical Sciences (IJCPS) welcomes high-quality, original manuscripts that advance knowledge in chemical sciences, pharmaceutical sciences, and allied health disciplines. Authors should carefully follow the instructions below before submitting their manuscripts.

Types of Manuscripts Accepted
It publishes the following article types:

Original Research Articles
Review Articles
Systematic Reviews and Meta-Analyses
Short Communications
Case Reports/Case Series
Clinical Studies
Editorials (by invitation)
Letters to the Editor
Perspectives and Commentary

General Requirements

Manuscripts must be original, unpublished, and not under consideration elsewhere.
The manuscript should be written in clear, concise English.
Authors are responsible for the scientific accuracy and integrity of the work.
All submissions must comply with international publication ethics and reporting standards.

Manuscript Preparation
Title Page Include:

Full manuscript title
Running title (maximum 50 characters)
Full names of all authors
Institutional affiliations
ORCID iD (recommended)
Corresponding author's name, email address, telephone number, and complete postal address

Abstract

Maximum 250 words
Structured for Original Articles:

Background
Methods
Results
Conclusion

Review Articles and Case Reports may use an unstructured abstract.

Keywords
Provide 3–6 keywords using Medical Subject Headings (MeSH) where appropriate.

Manuscript Structure
Original Research Articles

Title Page
Abstract
Keywords
Introduction
Materials and Methods
Results
Discussion
Conclusion
Acknowledgements
Funding Statement
Conflict of Interest
Author Contributions
References

Review Articles

Abstract
Keywords
Introduction
Main Review Sections
Future Perspectives
Conclusion
References

Case Reports

Abstract
Introduction
Case Presentation
Discussion
Conclusion
Patient Consent
References

Formatting Requirements

Microsoft Word (.doc or .docx)
Font: Times New Roman
Font size: 12 pt
Line spacing: Double
Margins: 2.5 cm (1 inch)
Continuous page numbering
Continuous line numbering is recommended.

Tables and Figures

Number consecutively using Arabic numerals.
Each table and figure must have a descriptive title.
Figures should be submitted in high resolution (minimum 300 dpi).
Authors must obtain permission for previously published material.

References
AJMPS follows the Vancouver referencing style.

Example:

Journal Article:
Sharma R, Kumar P, Singh A. Drug delivery systems in modern therapeutics. Asian J Med Pharm Sci. 2026;1(1):15–24.

Book:
Katzung BG. Basic and Clinical Pharmacology. 16th ed. New York: McGraw-Hill; 2024.

Website:
World Health Organization. Guidelines for Clinical Research. Available from: URL. Accessed July 2026.

Ethical Requirements
Authors must provide:

Ethics Committee/Institutional Review Board approval number (where applicable)
Informed patient consent for human studies
Animal ethics approval for animal experiments
Clinical trial registration number (if applicable)

Studies should comply with the Declaration of Helsinki and recognized ethical standards.

Authorship
It follows the ICMJE authorship criteria. Each author should have substantially contributed to:

Study conception or design
Data collection or analysis
Manuscript drafting or revision
Final approval of the manuscript

All authors share responsibility for the published work.

Conflict of Interest
All authors must disclose:

Financial relationships
Employment
Consultancy
Grants
Stock ownership
Patents
Any competing interests

If none exist, state:

"The authors declare no conflict of interest."

Funding Statement
Authors should clearly identify all sources of financial support.

Example:
"This research received no external funding."
(or)
"This work was supported by [Funding Agency], Grant No. XXXXX."

Data Availability Statement
Include a statement describing where supporting data can be accessed or explain any restrictions on availability.

Use of Artificial Intelligence (AI)
If AI-assisted tools (e.g., ChatGPT) were used for language editing or drafting, authors must disclose their use in the manuscript. AI tools must not be listed as authors, and authors remain fully responsible for the manuscript's content.

Plagiarism Policy

Manuscripts undergo plagiarism screening.
Similarity should generally be below 15%, excluding references and commonly used terminology.
Plagiarism, duplicate publication, and data fabrication will result in rejection.

Peer Review

Initial editorial screening
Double-blind peer review by at least two independent reviewers
Editorial decision:

Accept
Minor Revision
Major Revision
Reject

Editorial decisions are based on scientific quality, originality, ethical compliance, and relevance.

Copyright
Upon acceptance, authors retain copyright where applicable while granting journal the right to publish the article under the journal's copyright and licensing policy.

Submission Checklist
Before submission, ensure that:

Manuscript follows formatting requirements.
Title page is complete.
Abstract and keywords are included.
References are correctly formatted.
Tables and figures are properly labeled.
Ethics approval and patient consent statements are included where required.
Funding and conflict of interest statements are provided.
All authors have approved the final manuscript.

Editorial Contact
For manuscript-related queries, authors should contact the Editorial Office using the official journal Email ID: pharmaresearchlibrary@gmail.com

These guidelines are aligned with internationally recognized best practices for biomedical journals, including recommendations from the ICMJE and common standards used by peer-reviewed medical and pharmaceutical journals